Clusterin is a multifunctional apolipoprotein, and Clu’s involvement in the pathogenesis of AD may encompass lipid transport, Aβ deposition and clearance [52,64], tau pathology [65], and neuroinflammatory responses [27,66], which affect the blood–brain barrier (BBB) in AD. This evidence concerns the gene MAPT and Alzheimer disease.